Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today



Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Blood Thinner Linked to Increased Brain Bleeding

That raises risk of death from hemorrhagic stroke, researchers say

By Ed Edelson
HealthDay Reporter


Related Encyclopedia
 border=
Acoustic Neurinoma
Alzheimer's Disease
Aneurysms
Angina Pectoris
More...

Related Healthscout Videos
 border=
Importance of Good Nutrition
Controlling Incontinence
Preventing Heart Disease the Easy Way
Lifestyle Changes for Heart Disease Prevention and Treatment
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Angioplasty
Coronary Bypass Surgery
Erectile Dysfunction
More...

Related Drug Information
 border=
Accupril
Actonel
Adderal XR
Altace
More...

Related News Articles
 border=
High Blood Pressure Stalks Many Americans
Health Tip: Signs That a Child May Be Autistic
Exercise Keeps the Brain Young
FDA Approves New Drug for Severe Epilepsy
More...

MONDAY, Sept. 29 (HealthDay News) -- The amount of bleeding in the brain that occurs when a blood vessel bursts and causes a stroke is greater for some people who take the clot-preventing drug warfarin (Coumadin), a new study shows.

It's not a surprising finding, said Dr. Daniel Woo, an associate professor of neurology at the University of Cincinnati and co-author of the report in the Sept. 30 issue of Neurology, since it's long been established that the risk of death from such a stroke is greater for people taking warfarin.

Text Continues Below



But there has been a debate about whether the increased risk is due to an increased volume of blood spewed into the brain. The study of 258 people who had brain hemorrhages appears to settle the issue, Woo said: "We did find a larger volume of hemorrhage in these patients."

This general finding might not impress the estimated millions of Americans, most of them elderly, who are taking warfarin for a variety of reasons, such as prevention of potentially stroke-causing clots due to the abnormal heartbeat called atrial fibrillation. It is also taken by people with artificial heart valves or who have tiny blood clots in the lungs.

However, another, more specific finding from the study could be very important to these people. The excess bleeding was seen only in warfarin users with an INR of 3 or greater. INR, the international normalized ratio, is a measure of the ability of blood to clot properly.

"Normally, the INR is less than 2," Woo explained. "On warfarin treatment, the goal is to keep it between 2 and 3. In our study, if it was greater than 3, it was associated with a higher initial volume of hemorrhage. Between 1.2 and 3, there was not a significantly higher volume of hemorrhage."

But one person's INR can vary unpredictably, so regular blood tests are needed to be sure it is within the desired range, Woo said. "INR levels go up and down quite a bit," he said. "If it is too high, you run the risk of hemorrhage. If it is too low, you run the risk of whatever it is you are trying to prevent in the first place."

Page:  1 | 2 | Next >>

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 9/29/2008

Related Links
 border=
From Healthscout's partner site on heart disease, MyHeartCentral.com
Learn about heart disease symptoms.
Get more information on heart disease treatment for your health!
What can you do to prevent heart disease? Prevention details here.





SOURCES: Daniel Woo, M.D., associate professor, neurology; Matthew L. Flaherty, M.D., assistant professor, neurology, both of the University of Cincinnati; Sept. 30, 2008, Neurology


We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2008. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service